These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33197849)
1. Targeted degradation of CD147 proteins in melanoma. Zhou Z; Long J; Wang Y; Li Y; Zhang X; Tang L; Chang Q; Chen Z; Hu G; Hu S; Li Q; Peng C; Chen X Bioorg Chem; 2020 Dec; 105():104453. PubMed ID: 33197849 [TBL] [Abstract][Full Text] [Related]
2. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147. Yin Z; Cai H; Wang Z; Jiang Y Drug Des Devel Ther; 2020; 14():4561-4573. PubMed ID: 33149553 [TBL] [Abstract][Full Text] [Related]
3. Chemical proteomics reveal CD147 as a functional target of pseudolaric acid B in human cancer cells. Zhou Y; Di Z; Li X; Shan Y; Li W; Zhang H; Xiao Y Chem Commun (Camb); 2017 Aug; 53(62):8671-8674. PubMed ID: 28721406 [TBL] [Abstract][Full Text] [Related]
4. Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia Cells. Zou S; Parfenova E; Vrdoljak N; Minden MD; Spagnuolo PA Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928225 [TBL] [Abstract][Full Text] [Related]
5. Repressing CD147 is a novel therapeutic strategy for malignant melanoma. Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and in vivo and in vitro biological screening of pseudolaric acid B derivatives as potential anti-tumor agents. Xu Q; Deng H; Huang X; Liu JY; Chen GQ; Shen QK; Quan ZS; Guo HY; Yin XM Bioorg Chem; 2024 Oct; 151():107670. PubMed ID: 39096560 [TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy. Wu B; Cui J; Yang XM; Liu ZY; Song F; Li L; Jiang JL; Chen ZN Cell Death Dis; 2017 Jul; 8(7):e2925. PubMed ID: 28703811 [TBL] [Abstract][Full Text] [Related]
8. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945 [TBL] [Abstract][Full Text] [Related]
9. The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis. Zhang X; Huang Z; Guo Y; Xiao T; Tang L; Zhao S; Wu L; Su J; Zeng W; Huang H; Li Z; Tao J; Zhou J; Chen X; Peng C Oncogene; 2020 May; 39(21):4183-4197. PubMed ID: 32291412 [TBL] [Abstract][Full Text] [Related]
10. CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming. Kendrick AA; Schafer J; Dzieciatkowska M; Nemkov T; D'Alessandro A; Neelakantan D; Ford HL; Pearson CG; Weekes CD; Hansen KC; Eisenmesser EZ Oncotarget; 2017 Jan; 8(4):6742-6762. PubMed ID: 28039486 [TBL] [Abstract][Full Text] [Related]
11. Knockout of CD147 inhibits the proliferation, invasion, and drug resistance of human oral cancer CAL27 cells in Vitro and in Vivo. Pan S; Su Y; Sun B; Hao R; Gao X; Han B Int J Biol Macromol; 2021 Jun; 181():378-389. PubMed ID: 33766595 [TBL] [Abstract][Full Text] [Related]
12. CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma. Su J; Gao T; Jiang M; Wu L; Zeng W; Zhao S; Peng C; Chen X Oncotarget; 2016 Oct; 7(40):64778-64784. PubMed ID: 27556188 [TBL] [Abstract][Full Text] [Related]
13. Gamma-secretase complex-dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma. Yong YL; Zhang RY; Liu ZK; Wei D; Shang YK; Wu J; Zhang ZY; Li C; Chen ZN; Bian H J Pathol; 2019 Oct; 249(2):255-267. PubMed ID: 31215640 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of a Novel Small-molecule Compound as an Anticancer Inhibitor of CD147. Fu ZG; Wang Y; Wang S; Shao D; Tian L; Li YX; Jiang JL; Chen ZN; Wen N Biomed Environ Sci; 2019 Sep; 32(9):673-686. PubMed ID: 31635683 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol-induced apoptosis is associated with regulating the miR-492/CD147 pathway in malignant melanoma cells. Zhao S; Tang L; Chen W; Su J; Li F; Chen X; Wu L Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):797-807. PubMed ID: 33009925 [TBL] [Abstract][Full Text] [Related]
16. CD147 regulates melanoma metastasis via the NFAT1-MMP-9 pathway. Liu N; Qi M; Li K; Zeng W; Li J; Yin M; Liu H; Chen X; Zhang J; Peng C Pigment Cell Melanoma Res; 2020 Sep; 33(5):731-743. PubMed ID: 32339381 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression. Zhao S; Wu L; Kuang Y; Su J; Luo Z; Wang Y; Li J; Zhang J; Chen W; Li F; He Y; Tao J; Zhou J; Xu X; Peng C; Chen X Int J Oncol; 2018 Dec; 53(6):2397-2408. PubMed ID: 30272281 [TBL] [Abstract][Full Text] [Related]
18. CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma. Tang J; Guo YS; Zhang Y; Yu XL; Li L; Huang W; Li Y; Chen B; Jiang JL; Chen ZN Cell Death Differ; 2012 Nov; 19(11):1779-90. PubMed ID: 22595757 [TBL] [Abstract][Full Text] [Related]
19. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells. Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566 [TBL] [Abstract][Full Text] [Related]
20. CD147/basigin promotes progression of malignant melanoma and other cancers. Kanekura T; Chen X J Dermatol Sci; 2010 Mar; 57(3):149-54. PubMed ID: 20060267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]